Takuma Nakatsuka
Director of Finance/CFO at Quantum Biosystems, Inc.
Profile
Takuma Nakatsuka was the founder of Vasculead, Inc. (founded in 2017) where he held the title of Auditor.
He is currently the Chief Financial Officer & Director at GORYO Chemical, Inc. and the Co-CFO & Manager-Business Administration at Quantum Biosystems, Inc. Mr. Nakatsuka's former positions include Chief Executive Officer at Genomedia, Inc., CFO, Director & Investor Relations Contact at NANO MRNA Co., Ltd.
(from 2013 to 2014), Principal at Hosokawa Micron Corp., Chief Financial Officer at AnGes, Inc., Principal at Veolia Japan KK, Principal at Nishihara Environment Technology, Inc., and Chief Financial Officer at Nihon Schering KK.
Mr. Nakatsuka's education includes a graduate degree from the University of Michigan, a graduate degree from the University of Tokyo, and an MBA from The Wharton School of the University of Pennsylvania.
Takuma Nakatsuka active positions
| Companies | Position | Start |
|---|---|---|
Quantum Biosystems, Inc.
 Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Director of Finance/CFO | - |
GORYO Chemical, Inc.
 GORYO Chemical, Inc. Chemicals: Major DiversifiedProcess Industries GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan. | Director of Finance/CFO | - |
Former positions of Takuma Nakatsuka
| Companies | Position | End |
|---|---|---|
| NANO MRNA CO.,LTD. | Director of Finance/CFO | 2014-12-30 |
Vasculead, Inc.
 Vasculead, Inc. Financial ConglomeratesFinance Vasculead, Inc. provides investment services. The company is based in Osaka, Japan. The Japanese company was founded in 2017 by Takuma Nakatsuka, Yosuke Suzuki, Takeshi Akatsu, Nobuyuki Takakura. Yosuke Suzuki has been the CEO since 2017. | Founder | - |
Nishihara Environment Technology, Inc.
 Nishihara Environment Technology, Inc. Engineering & ConstructionIndustrial Services Part of Veolia Environnement SA, Nishihara Environment Technology, Inc. constructs and operates water treatment facilities. The company is based in Tokyo, Japan. | Corporate Officer/Principal | - |
Veolia Japan KK
 Veolia Japan KK Water UtilitiesUtilities Veolia Japan KK engages in the provision of water, energy and materials solutions focusing on waste receovery. Its services include operation and maintenance of water and wastewater treatment facilities; design, construction, and management of water and wastewater treatment facilities; pipe network management; platic recycling and renewable energy. The company was founded on May 1, 2002 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | - |
| HOSOKAWA MICRON CORPORATION | Corporate Officer/Principal | - |
Training of Takuma Nakatsuka
| University of Tokyo | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| University of Michigan | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NANO MRNA CO.,LTD. | Health Technology |
| ANGES, INC. | Health Technology |
| HOSOKAWA MICRON CORPORATION | Producer Manufacturing |
| Private companies | 7 |
|---|---|
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
Nihon Schering KK
 Nihon Schering KK Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Nihon Schering KK is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The company is based in Osaka, Japan. | Health Technology |
Genomedia, Inc.
 Genomedia, Inc. Miscellaneous Commercial ServicesCommercial Services Genomedia, Inc. is a Japanese company that provides one-stop and high-efficiency genome information analysis services, from sample preparation to software tool development. The company was founded in 2013 and is based in Tokyo, Japan. The company specializes in the development and provision of diagnostic services using genomic information, as well as the development of tools required to perform genome information analysis. | Commercial Services |
Veolia Japan KK
Veolia Japan KK Water UtilitiesUtilities Veolia Japan KK engages in the provision of water, energy and materials solutions focusing on waste receovery. Its services include operation and maintenance of water and wastewater treatment facilities; design, construction, and management of water and wastewater treatment facilities; pipe network management; platic recycling and renewable energy. The company was founded on May 1, 2002 and is headquartered in Tokyo, Japan. | Utilities |
Nishihara Environment Technology, Inc.
Nishihara Environment Technology, Inc. Engineering & ConstructionIndustrial Services Part of Veolia Environnement SA, Nishihara Environment Technology, Inc. constructs and operates water treatment facilities. The company is based in Tokyo, Japan. | Industrial Services |
Vasculead, Inc.
Vasculead, Inc. Financial ConglomeratesFinance Vasculead, Inc. provides investment services. The company is based in Osaka, Japan. The Japanese company was founded in 2017 by Takuma Nakatsuka, Yosuke Suzuki, Takeshi Akatsu, Nobuyuki Takakura. Yosuke Suzuki has been the CEO since 2017. | Finance |
GORYO Chemical, Inc.
GORYO Chemical, Inc. Chemicals: Major DiversifiedProcess Industries GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan. | Process Industries |
- Stock Market
- Insiders
- Takuma Nakatsuka
